Integrative oncology: Addressing the global challenges of cancer prevention and treatment
JJ Mao, GG Pillai, CJ Andrade… - CA: A Cancer …, 2022 - Wiley Online Library
The increase in cancer incidence and mortality is challenging current cancer care delivery
globally, disproportionally affecting low‐and middle‐income countries (LMICs) when it …
globally, disproportionally affecting low‐and middle‐income countries (LMICs) when it …
Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update
CL Loprinzi, C Lacchetti, J Bleeker… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To update the ASCO guideline on the recommended prevention and treatment
approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in …
approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in …
Integrative medicine for pain management in oncology: society for integrative oncology–ASCO guideline
JJ Mao, N Ismaila, T Bao, D Barton… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other health care providers on integrative approaches to …
practicing physicians and other health care providers on integrative approaches to …
[HTML][HTML] Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention …
Central and especially peripheral neurotoxicities due to systemic antineoplastic therapy are
common and often dose-limiting side-effects. In patients with chemotherapy (ChT)-induced …
common and often dose-limiting side-effects. In patients with chemotherapy (ChT)-induced …
Acupuncture for chemotherapy‐induced peripheral neuropathy in breast cancer survivors: A randomized controlled pilot trial
Background Chemotherapy‐induced peripheral neuropathy (CIPN) is one of the most
debilitating long‐term side effects in breast cancer survivors. We conducted a randomized …
debilitating long‐term side effects in breast cancer survivors. We conducted a randomized …
[HTML][HTML] Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral …
AJM Beijers, CS Bonhof, F Mols, J Ophorst… - Annals of …, 2020 - Elsevier
Background This study investigated the efficacy and tolerability of wearing frozen gloves
(FGs) during chemotherapy to prevent chemotherapy-induced peripheral neuropathy (CIPN) …
(FGs) during chemotherapy to prevent chemotherapy-induced peripheral neuropathy (CIPN) …
The efficacy of acupuncture in chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis
TJ Chien, CY Liu, CJ Fang… - Integrative cancer …, 2019 - journals.sagepub.com
Background: Chemotherapy-induced peripheral neuropathy (CIPN) has no cure, but
acupuncture may provide relief through its known neuromodulation or neuroendocrine …
acupuncture may provide relief through its known neuromodulation or neuroendocrine …
Safety of acupuncture in oncology: a systematic review and meta‐analysis of randomized controlled trials
MD Höxtermann, H Haller, S Aboudamaah… - Cancer, 2022 - Wiley Online Library
Background Acupuncture is frequently used to treat the side effects of cancer treatment, but
the safety of this intervention remains uncertain. The current meta‐analysis was conducted …
the safety of this intervention remains uncertain. The current meta‐analysis was conducted …
Managing chronic neuropathic pain: recent advances and new challenges
N Hange, S Poudel, S Ozair, T Paul… - Neurology Research …, 2022 - Wiley Online Library
Aim. Neuropathic pain affects 7–10% of the population, with most of the patients receiving
inadequate and incomplete treatment. Owing to the high financial burden and the poor …
inadequate and incomplete treatment. Owing to the high financial burden and the poor …